(19)
(11) EP 2 442 803 A1

(12)

(43) Date of publication:
25.04.2012 Bulletin 2012/17

(21) Application number: 10790086.2

(22) Date of filing: 15.06.2010
(51) International Patent Classification (IPC): 
A61K 31/397(2006.01)
(86) International application number:
PCT/US2010/038742
(87) International publication number:
WO 2010/148040 (23.12.2010 Gazette 2010/51)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(30) Priority: 15.06.2009 US 187251 P
22.01.2010 US 297696 P

(71) Applicant: Salix Pharmaceuticals, Ltd.
Raleigh, NC 27615 (US)

(72) Inventor:
  • FORBES, William
    Raleigh NC 27614 (US)

(74) Representative: Adam, Holger 
Kraus & Weisert Patent- und Rechtsanwälte Thomas-Wimmer-Ring 15
80539 München
80539 München (DE)

   


(54) MODULATION OF SYSTEMIC EXPOSURE TO RIFAXIMIN